Ning Yang

Ning Yang

Auto-generated profile, based on publicly available information

Ning Yang

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
NYNing Yang
Ning Yang
WMWenmei Ma
Wenmei Ma
YKYing Ke
Ying Ke
HLHui Liu
Hui Liu
JCJin Chu
Jin Chu
LRLin Renyong
Lin Renyong
Background: Alveolar echinococcosis (AE) can cause severe liver fibrosis and could be fatal if left untreated. Currently, there are no effective therapeutic options for AE-induced liver fibrosis. In view of the therapeutic potential of adipose-derived stem cells (ADSCs), we investigated whether ADSCs transplantation has the ability to control or reverse fibrosis progression in the liver ofEchinococcus multilocularis(E.multilocularis) infected mice.Methodology/Principal findings: C57BL/6 mice infected withE.multilocularisthrough portal vein inoculation were intravenously injected with ADSCs isolated from inguinal adipose tissues of 6–8 weeks old mice. Histopathological analysis including heamatoxylin & eosin staining as well as Masson’s trichrome staining, and Sirius red staining were performed to access the degree of liver fibrosis. Histopathological examination 30 days after ADSCs transplantation revealed that ADSCs significantly decreased the degree of liver fibrosis inE.multilocularisinfected mice by inhibiting the expressions of α-SMA and type 1 collagen deposition. In addition, compared to the non-transplanted group, ADSCs transplantation reduced fibrotic areas inE.multilocularisinfected mice. We also found that ADSCs transplantation significantly down-regulated TGF-β1 and TGF-βR expressions, while up-regulating Smad7 expression in the TGF-β/Smad signaling pathway.Conclusions: ADSCs can alleviateEchinococcus multilocularisinfection-induced liver fibrosis by modulating the activity level of the TGF-β/Smad7 signaling pathway and provide a potential therapeutic approach forE.multilocularis-induced fibrosis.

26 November 2018 in Parasite
Verified
Journal Article
Open access
HWHui Wang
Hui Wang
JLJun LI
Jun LI
CZChuan shan Zhang
Chuan shan Zhang
BGBaoping Guo
Baoping Guo
QWQin Wei
Qin Wei
HWHao Wen
Hao Wen
Cystic echinococcosis (CE) is a cosmopolitan parasitic disease caused by infection with the larval stage of Echinococcus granulosus sensu lato. Thioredoxin peroxidase (TPx) may play an essential role in the antioxidant defence system of E. granulosus s.l. as neither catalase nor glutathione peroxidase activities have been detected in the parasite. However, it is not known whether TPx affects the survival and growth of E. granulosus s.l. during development. In this study, three fragments of siRNA specific for EgTPx (siRNA-1/2/3) were designed and transfected into protoscoleces of E. granulosus sensu stricto by electroporation. Quantitative real-time PCR and Western blotting analysis showed that siRNA-3 significantly reduced the expression of EgTPx. Coincidentally, knockdown of EgTPx expression in protoscoleces with siRNA-3 significantly reduced the viability of the parasite under oxidative stress induced by 0.6 mM H2O2. In vitro culture studies showed that protoscoleces treated with siRNA-3 reduced pre-microcyst formation. In vivo experiments showed that injecting mice intraperitoneally with protoscoleces treated with siRNA-3 resulted in a significant reduction in the number, size and weight of CE cysts compared with those of control animals. Silencing of EgTPx led to the impairment of growth of E. granulosus s.s. both in vitro and in vivo, indicating that EgTPx is an important factor for protoscoleces survival and plays an important role in the antioxidant defence against the host during development.

1 March 2022 in Acta Tropica
Verified
Journal Article
Open access
YKYing Ke
Ying Ke
XBXiaojuan Bi
Xiaojuan Bi
NYNing Yang
Ning Yang
Jin ChuJin Chu
Jin Chu
XLXiaohong Li
Xiaohong Li
LRLin Renyong
Lin Renyong
Alveolar echinococcosis (AE) is a chronic disease caused by the larval stage of Echinococcus multilocularis. Assessing the metabolic activity of AE lesions is critical to evaluate disease progression and survey treatment options. There is an urgent need to identify more rapid, convenient, and non-invasive clinical detection methods to substitute the current techniques. Herein, we evaluated the viability of platelet-derived growth factor-BB (PDGF-BB) as a biomarker for detecting the metabolic activity of AE patients and their correlations with clinicopathological features of AE patients. Sera were collected from 28 AE patients and a homogenous cohort of 28 healthy individuals. The concentration of serum PDGF-BB homodimers (sPDGF-BB) was assessed via an enzyme-linked immunosorbent assay (ELISA). Liver tissue samples were obtained from a consecutive series of 28 AE patients who underwent surgical resection. Thereafter, we determined the expression levels of local PDGF-BB and platelet-derived growth factor receptor-β (PDGFR-β) through immunohistochemistry (IHC). Correlations of PDGF-BB expression levels with clinicopathological features of AE patients were analyzed using SPSS. The concentrations of sPDGF-BB were significantly lower in AE patients (p < 0.0001), particularly in High Metabolically Active AE patients (HMAE) patients (p < 0.05). The expression levels of PDGF-BB and its receptor were both significantly higher in close liver tissue (CLT) in AE patients (p < 0.0001). We also found that metabolically active AE and sPDGF-BB are significantly negatively correlated (r = -0.624, p = 0.0004). Beside, the local expression levels of PDGF-BB was positively correlated with metabolic activity, PNM stage, and lesion size. Notably, the sPDGF-BB levels were proposed as a potential biomarker for assessing metabolic activity of AE, with 81.0% sensitivity and 85.7% specificity (95% confidence interval, p = 0.003). Serum levels of PDGF-BB could be a simple, non-invasive, and quick biomarker for assessing the metabolic activity of lesions in AE patients.

17 May 2022 in Zeitschrift für Gastroenterologie
Verified
Journal Article
Closed access
PDF file
SPShu-Jie Pang
Shu-Jie Pang
ZLZhi-Peng Lin
Zhi-Peng Lin
ZSZhe Sun
Zhe Sun
YZYu Zhang
Yu Zhang
ZYZhengang Yuan
Zhengang Yuan
NYNing Yang
Ning Yang
Background The current meta-analysis was conducted to determine whether antithrombotic drug use would affect the diagnostic accuracy of fecal occult blood testing for advanced colorectal neoplasia. Methods Articles published between 2000 and 2019 were systematically retrieved and screened according to the inclusion and exclusion criteria by two reviewers independently. Pooled analyses were conducted with a fixed-effect model if no apparent heterogeneity (I2 ≥ 50%) was found between studies; otherwise, the random effects model would be used. Sensitivity analysis and subgroup analysis were also conducted using Review Manager 5.3. Results Pooled analysis revealed that aspirin and nonsteroidal anti-inflammatory drugs were associated with a decrease in the positive predictive value of fecal occult blood testing for advanced colorectal neoplasia screening, with a RR of 0.89 (95% CI: 0.84–0.94) and 0.88 (95% CI: 0.84–0.93, p<0.001) respectively. Subgroup analysis based on data limited to high-quality studies, fecal immunochemical testing, or in Caucasians also showed that the use of aspirin/NSAID drugs decreased the accuracy for advanced colorectal neoplasia screening. Conclusion Aspirin/NSAIDs and direct oral anticoagulants rather than warfarin may decrease the diagnostic accuracy of fecal occult blood testing for advanced colorectal neoplasia screening. Hintergrund Das Hauptziel dieser Meta-Analyse war herauszufinden, ob die Anwendung antithrombotischer Medikamente die diagnostische Genauigkeit von Tests auf okkultes Blut im Stuhl bei fortgeschrittener kolorektaler Neoplasie beeinflussen würde. Methoden 2 unabhängige Gutachter recherchierten systematisch Publikationen, die zwischen 2000 und 2019 veröffentlicht wurden, basierend auf bestimmten Ein- und Ausschlusskriterien. Gepoolte Analysen wurden unter Verwendung eines Fixed-Effects-Modells durchgeführt, in denen keine offensichtliche Heterogenität (I2 ≥ 50 %) zwischen den Studien festgestellt wurde; andernfalls wurde das Random-Effects-Modell verwendet. Review Manager 5.3 wurde verwendet, um Sensitivitäts- und Subgruppenanalysen durchzuführen. Ergebnisse Die gepoolte Analyse ergab, dass Aspirin und nichtsteroidale Antirheumatika (NSAR) mit einer Abnahme des positiven Vorhersagewerts von Tests auf okkultes Blut im Stuhl für das Screening auf kolorektale fortgeschrittene Neoplasien assoziiert waren; also mit einem RR von 0,89 (95 % KI: 0,84–0,94) und 0,88 (95 % KI: 0,84–0,93, p < 0,001). Die Subgruppenanalyse basierte auf Daten, die auf qualitativ hochwertige Studien, immunchemische Tests im Stuhl oder asiatische und europäische Populationen beschränkt waren. Die Analyse ergab, dass die Verwendung von Aspirin/NSAR-Medikamenten die Genauigkeit des Screenings auf fortgeschrittene kolorektale Neoplasie verringerte. Schlussfolgerung Aspirin/NSAR und direkte orale Antikoagulanzien anstelle von Warfarin können die diagnostische Genauigkeit des Tests auf okkultes Blut im Stuhl beim Screening auf fortgeschrittene kolorektale Neoplasien verringern. Received: 23 November 2021 Accepted after revision: 04 April 2022 Article published online: 17 May 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany